Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 811. The contact email is not on this page.
- SIMMERSION, LLC.
NIH R44: Applied Social Cognitive Skills in the Workplace for Transition-Aged Youth with Autism Spectrum Disorder
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- New Health Sciences, Inc.
Form D history: Other Health Care
startup · MA · amount not stated · 2025-08-05
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-08-05.
- PEARLHILL TECHNOLOGIES, LLC
NIH R41: Environmental Sensor for Detection of PFAS
startup · ID · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MABSWITCH, INC.
NIH R43: LentiSAFE Ligands: Mild-Elution Immunoaffinity Ligands for Enrichment and Purification of Lentiviral Vectors
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ENTOX SCIENCES, LLC
NIH R41: Rapid Control and Assessment of Dissolved Gas Signals on Tissue Function andDisease.
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- DOXY.ME, LLC
NIH R44: Doxy.me VR: A scalable virtual reality app to facilitate evidence-based immersive telemental health
startup · SC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PERICOR, LLC
NIH R41: PeriScope: A Novel Videoscope and Toolkit to Enable Fluoro-free Pericardial Access for Epicardial Ablation
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- REHABTEK, LLC
NIH U44: Facilitating neuroplastic changes of acute stroke survivors with severe hemiplegia
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ACOUFLOW THERAPEUTICS, LLC
NIH R41: Toward Establishing the Feasibility and Commercial Readiness of VortexPAP for Improving OSA Treatment
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PROALLOSTERA PHARMACEUTICALS, INC.
NIH R41: Targeting Proteasome Dysfunction for the Treatment of Alzheimer’s Disease
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- KUHLER TECHNOLOGIES INC.
NIH R41: Active Thermoregulation with Palm Cooling for Efficient Human-Climate Adaptation
startup · VT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SONORAN BIOSCIENCES, INC.
NIH R44: Extended-release injectable gel for multi-day treatment of postoperative pain
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ENDIOS BIO, INC.
NIH R43: Development of antisense oligonucleotides against PEG10 in the fight against ALS-FTD
startup · LA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MEDIACOMBO, INC.
NIH R43: VITaLS: Visual Thinking and Learning Strategies: Enhancing Health Professions Education through Virtual Reality Enabled Art Museum Experiences
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- FRAMERGY, INC.
NIH R43: A Novel Approach for the At Home Detection of PFAS in Drinking Water
startup · DE · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PROTEOVISTA, LLC
NIH R43: Development of the High-Density SNAP-Dimer Microarray for Functional Analysis of Dimeric Protein Complexes
startup · WI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- IHP THERAPEUTICS, INC.
NIH R44: Development of a novel disease-modifying glycan therapeutic for early at-home intervention of acute vaso-occlusive crisis in sickle cell disease
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PRIMETIME LIFE SCIENCES, LLC
NIH R44: Development of PTLS-209 for treatment for giardiasis
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HALO BIOSCIENCES, INC.
NIH R44: Development of a Novel Hyaluronan Inhibitor for the Treatment of Group 3 Pulmonary Hypertension (PH)
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- UNAR LABS, LLC
NIH R42: STTR Phase II - Development of a visual-to-tactile conversion system for automating the tactile graphic generation process
startup · ME · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ACTINIA INC
NIH R43: High-resolution energy-integrating computed tomography scanners using direct-conversion detectors made from cesium lead bromide
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- 3D BIOANALYTIX, INC.
NIH R41: Development of a blood-based test for neurodegenerative diseases
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Boulder Care
Boulder Care offers telehealth addiction treatment grounded in kindness, respect, and unconditional support. Their program is designed by addiction medicine specialists and people with lived experience of recovery, focusing on improving the lives of individuals with substance use
startup · OR · amount not stated · 2024-05-21
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-05-21.
- SCHEDULE 1 THERAPEUTICS, INC.
NIH R44: Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- KATHERA BIOSCIENCE INC.
NIH R43: A Redesigning Existing Drugs against Indispensable Targets (ReEDIT) platform technology for discovery of novel drugs to treat fungal infections
startup · NJ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MAX BIOPHARMA, INC.
NIH R44: Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Taxis Pharmaceuticals, Inc.
Form D history: Pharmaceuticals
startup · NJ · amount not stated · 2019-01-10
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2019-01-10.
- WEINBERG MEDICAL PHYSICS, LLC
NIH R41: Treating Balance Impairment of the Elderly with TMS-induced Brain Connectivity
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- QATCH TECHNOLOGIES, LLC
NIH R44: High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AMPEDRNA BIOSCIENCES LLC
NIH R43: Highly stable mini-circRNA vaccine with maximally activated and long-lasting T cells for HPV-related cancer combination immunotherapy
startup · VA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PRECISION BIOTOOLS INC
NIH R44: A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
startup · CT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ACOUSTIC RANGE ESTIMATES, LLC
NIH R44: Thermoacoustic Range Verification During Delivery of a Clinical Plan by a Synchrocyclotron: transition from research prototype to turnkey clinical device
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Alleviant Medical, Inc.
Form D history: Other Health Care
startup · TX · amount not stated · 2025-01-27
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-01-27.
- COHERE-MED, INC.
NIH R42: Solving Sepsis: Early Identification and Prompt Management Using Machine Learning
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Cellinfinity Bio Holding Company, LLC
Form D history: Biotechnology
startup · CT · amount not stated · 2022-08-12
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2022-08-12.
- NXTECH INC
NIH R44: BoostPrime, A Novel Digital Therapeutic for Craving Mitigation in OUD
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Moonlight Therapeutics Inc.
Form D history: Biotechnology
startup · GA · amount not stated · 2024-08-16
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-08-16.
- SEACOAST SCIENCE, INC.
NIH R44: Auto-calibrating, Air Quality Monitoring System
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CathBuddy, Inc.
Form D history: Other Health Care
startup · NY · amount not stated · 2024-02-26
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-02-26.
- ZABBIO, INC.
NIH R44: Development of a monoclonal therapy for neonatal herpes
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.